col blocks we are bridge builder col blocks
COVID answers in Scientific Journals all over the world


175 Results       Page 1

 [1] 
Future Medicine: Future Virology
  original article Date Title Authors   Max. 6 Authors
1 [GO] 2024―Mar―18 Direct virus capture assay for label-free detection of SARS-CoV-2 virions using laser microscopy Alessandro Pennesi, Guglielmo Ferrari, Federica Giardina, Sara Piselli, Roberto Lo Savio, Adolfo Carloni, Stefania Paolucci, Fausto Baldanti
2 [GO] 2024―Feb―26 Real-life use of high-dose anakinra in patients with COVID-19 treated with remdesivir Roberta Monardo, Andrea Mastrangelo, Laura Galli, Alessandro Tomelleri, Vincenzo Spagnuolo, Chiara Oltolini, Giacomo Ponta, Corrado Campochiaro, Giulio Cavalli, Lorenzo Dagna, Fabio Ciceri, Paola Cinque, Paolo Scarpellini, Antonella Castagna, Marco Ripa
3 [GO] 2024―Feb―09 Developing a risk prediction model for COVID-19 infection in heart transplant recipients using artificial intelligence Shriya Sharma, Nora Menon, Jose Ruiz, Caitlyn Luce, Lisa Brumble, Anirban Bhattacharya, Rohan Goswami
4 [GO] 2024―Feb―05 Preliminary application of a coronavirus pseudovirus system Xiaoli Tao, Tengfei Li, Baojun He, Wei Zhao, Siman Hu, Zhuping Ma, Lvyin Sun, Runlin Li, Like Luo, Yonggang Li
5 [GO] 2023―Dec―21 Resistance analysis following sotrovimab treatment in participants with COVID-19 during the phase III COMET-ICE study Sambhavi Subramanian, Gretja Schnell, Julia di Iulio, Anil K Gupta, Adrienne E Shapiro, Elias H Sarkis, Amanda Lopuski, Amanda Peppercorn, Melissa Aldinger, Christy M Hebner, Andrea L Cathcart
6 [GO] 2023―Dec―19 Effect of the COVID-19 pandemic on the reporting of Crimean-Congo hemorrhagic fever Mohammad Hassan Pouriayevali, Ehsan Mostafavi, Mehdi Fazlalipour, Tahmineh Jalali, Sahar Khakifirouz, Seyed Dawood Mosavi-Nasab, Mostafa Salehi-Vaziri
7 [GO] 2023―Nov―07 Validation of a risk prediction model for COVID-19: the PERIL prospective cohort study Shahd A Mohammedain, Saif Badran, AbdelNaser Y Elzouki, Halla Salim, Ayesha Chalaby, MYA Siddiqui, Yehia Y Hussein, Hanan Abdul Rahim, Lukman Thalib, Mohammed Fasihul Alam, Daoud Al-Badriyeh, Sumaya Al-Maadeed, Suhail AR Doi
8 [GO] 2023―Nov―07 Antiviral attributes of bee venom as a possible therapeutic approach against SARS-CoV-2 infection Soumik Goswami, Jayita Pal Chowdhury
9 [GO] 2023―Nov―01 Oral bemnifosbuvir (AT-527) vs placebo in patients with mild-to-moderate COVID-19 in an outpatient setting (MORNINGSKY) Arantxa Horga, Rebecca Saenz, Gürdal Yilmaz, Abraham Simón-Campos, Keith Pietropaolo, William J Stubbings, Neil Collinson, Laura Ishak, Barbara Zrinscak, Bruce Belanger, Catherine Granier, Kai Lin, Aeron C Hurt, Xiao-Jian Zhou, Steffen Wildum, Janet Hammond
10 [GO] 2023―Oct―26 In silico identification of deep-sea fungal alkaloids as potential inhibitors of SARS-CoV-2, Delta and Omicron spikes Abdullah R Alanzi, Mohammad K Parvez, Mohammed S Al-Dosari
11 [GO] 2023―Oct―18 Genotoxicity: a neglected but potentially critical aspect of adenoviral COVID-19 vaccines Alireza Mardomi, Tahoora Mousavi, Farahnoosh Farnood, Hamid Tayebi Khosroshahi
12 [GO] 2023―Sep―19 ‘The end’ - or is it? Emergence of SARS-CoV-2 EG.5 and BA.2.86 subvariants Farid Rahimi, Mohammad Darvishi, Amin Talebi Bezmin Abadi
13 [GO] 2023―Sep―11 Targeting host calcium channels and viroporins: a promising strategy for SARS-CoV-2 therapy Mona Fani, Maryam Moossavi, Hasan Bakhshi, Abozar Nasiri Jahrodi, Mohammad Reza Khazdair, Amir Hossein Zardast, Shokouh Ghafari
14 [GO] 2023―Jul―28 Plain Language Summary of a Clinical Trial Evaluating mRNA-1273, Moderna's mRNA-Based COVID-19 Vaccine, in Children 6 Through 11 Years of Age CB Creech, E Anderson, V Berthaud, I Yildirim, AM Atz, I Melendez Baez, D Finkelstein, P Pickrell, J Kirstein, C Yut, R Blair, RA Clifford, M Dunn, JD Campbell, DC Montefiori, JE Tomassini, X Zhao, W Deng, H Zhou, D Ramirez Schrempp, K Hautzinger, B Girard, K Slobod, R McPhee, R Pajon, R Das, JM Miller, S Schnyder Ghamloush
15 [GO] 2023―Jul―13 Expression of TRIM56 gene in SARS-CoV-2 variants and its relationship with progression of COVID-19 Rezvan Tavakoli, Pooneh Rahimi, Mojtaba Hamidi-Fard, Sana Eybpoosh, Delaram Doroud, Iraj Ahmadi, Enayat Anvari, Mohammadreza Aghasadeghi, Abolfazl Fateh
16 [GO] 2023―Jun―24 Design and generation of mRNAs encoding conserved regions of SARS-CoV-2 ORF1ab for T cell-mediated immune activation Cao Minh Nguyen, Bac An Luong, Thu Thuy Thi Tran, Hoai Nghia Nguyen, Le Son Tran
17 [GO] 2023―Jun―23 Phase II study of bemnifosbuvir in high-risk participants in a hospital setting with moderate COVID-19 Arantxa Horga, Daniel R. Kuritzkes, John J. Kowalczyk, Keith Pietropaolo, Bruce Belanger, Kai Lin, Kristen Perkins, Janet Hammond
18 [GO] 2023―Jun―16 COVID-19 post vaccination neuronal adverse events: probable mechanisms and treatment possibilities Abdul Mannan Baig, Joachim Gerlach, Prakash Salunke, Rachel Jessey, Robin Rose
19 [GO] 2023―Jun―16 Effects of COVID-19 and vaccination on the human immune system: cases of lymphopenia and autoimmunity Joachim Gerlach, Abdul Mannan Baig
20 [GO] 2023―Jun―07 Plant protease inhibitors against SARS-CoV-2 main protease: an in silico approach Adrianne M Lima, Adson A de Souza, Jackson L Amaral, Valder N Freire, Pedro F N Souza, Hermógenes D de Oliveira
21 [GO] 2023―Jun―01 CpG 684: an effective adjuvant for the inactivated COVID-19 vaccine in mice Jiandong Liu, Tianle Cang, Congli Jiang, Kelei Li, Siyuan Liu, Haixin Wang, Meirong Wang, Yan Chen, Yan Shao, Jiankai Liu
22 [GO] 2023―Jun―01 Structure-based virtual identification of natural inhibitors of SARS-CoV-2 and its Delta and Omicron variant proteins Abdullah R Alanzi, Mohammad K Parvez, Mohammed S Al-Dosari
23 [GO] 2023―May―22 In silico assessment of diterpenes as potential inhibitors of SARS-COV-2 main protease Yousef A Abdelrady, Naeem Mahmood Ashraf, Arslan Hamid, Hayam S Thabet, Asmaa M Sayed, Shimaa H Salem, Emad HM Hassanein, Ahmed M Sayed
24 [GO] 2023―May―22 Identification of host factors that bind to the 5′ end of the MERS-CoV RNA genome Bader Y Alhatlani, Waleed Aljabr, Fatimah S Alhamlan, Ahmad Almatroudi, Mohd Azam, Mansour Alsaleem, Khaled S Allemailem
25 [GO] 2023―Apr―17 Efficiency rating of SG Diagnostics COVID-19 antigen rapid test kit Francesco Chirico, Murat Yıldırım, Tomasz Dzieciatkowski, Marek Dabrowski, Marek Malysz, Marcin Madziala, Milosz Jaroslaw Jaguszewski, Karol Bielski, Gabriella Nucera, Krzysztof J Filipiak, Lukasz Szarpak
26 [GO] 2023―Apr―11 DPP-4 Inhibitors as a savior for COVID-19 patients with diabetes Snehasish Nag, Samanwita Mandal, Oindrila Mukherjee, Suprabhat Mukherjee, Rakesh Kundu
27 [GO] 2023―Apr―11 In silico analysis of ACE2 from different animal species provides new insights into SARS-CoV-2 species spillover Felipe Pantoja Mesquita, Pedro Filho Noronha Souza, Dyane Rocha Aragão, Expedito Maia Diógenes, Emerson Lucena da Silva, Jackson Lima Amaral, Valder Nogueira Freire, Débora de Souza Collares Maia Castelo-Branco, Raquel Carvalho Montenegro
28 [GO] 2023―Apr―06 The impact of mutation sets in receptor-binding domain of SARS-CoV-2 variants on the stability of RBD-ACE2 complex Mykyta Peka, Viktor Balatsky
29 [GO] 2023―Apr―04 Evidence-based policies in public health to address COVID-19 vaccine hesitancy Francesco Chirico, Jaime A Teixeira da Silva
30 [GO] 2023―Mar―14 Natural killer cells in COVID-19: from infection, to vaccination and therapy Alireza Zafarani, Mohammad Hossein Razizadeh, Salar Pashangzadeh, Mohammad Reza Amirzargar, Mahsa Taghavi-Farahabadi, Mohammad Mahmoudi
31 [GO] 2023―Mar―09 A twisting tale of misinformation: should ivermectin be approved as a treatment for COVID-19 disease? Arman Shafiee, Mohammad Mobin Teymouri Athar, Sayed-Hamidreza Mozhgani
32 [GO] 2023―Mar―06 Two sides of the same coin: the N-terminal and the receptor binding domains of SARS-CoV-2 Spike Massimo Ciccozzi, Stefano Pascarella
33 [GO] 2023―Feb―20 HLA and red blood cell antigen genotyping in SARS-CoV-2 convalescent plasma donors William Lemieux, Josée Perreault, Gabriel André Leiva-Torres, Nadia Baillargeon, Jessica Constanzo Yanez, Marie-Claire Chevrier, Lucie Richard, Antoine Lewin, Patrick Trépanier
34 [GO] 2023―Feb―03 SARS-CoV-2 RNA-dependent RNA polymerase as a target for high-throughput drug screening Jiahui Wu, Zhiqiang Chen, Xue Han, Qiaoqiao Chen, Yintao Wang, Tingting Feng
35 [GO] 2023―Jan―27 Is the emergence of the zoonotic Langya virus amidst COVID-19 and monkeypox a cause for concern? Chandan Kumar Thakur, Jog Bahadur Adhikari, Nitin Gupta, Prakash Ghimire, Meghnath Dhimal
36 [GO] 2023―Jan―19 Update on the treatment of multisystem inflammatory syndrome in children associated with COVID-19 Fangyuan Long, Shiheng Zhu, Zeguang Wang, Shungeng Zhang, Jinlong He, Xinbin Ge, Jun Ning
37 [GO] 2023―Jan―16 Plain language summary of Pfizer-BioNTech BNT162b2 vaccine protection against COVID-19 and its safety in participants 12- to 15-years-old Robert W Frenck, Nicola P Klein, Nicholas Kitchin, Alejandra Gurtman, Judith Absalon, Stephen Lockhart, John L Perez, Emmanuel B Walter, Shelly Senders, Ruth Bailey, Kena A Swanson, Hua Ma, Xia Xu, Kenneth Koury, Warren V Kalina, David Cooper, Timothy Jennings, Donald M Brandon, Stephen J Thomas, Özlem Türeci, Dina B Tresnan, Susan Mather, Philip R Dormitzer, Uğur Şahin, Kathrin U Jansen, William C Gruber
38 [GO] 2023―Jan―10 Diagnosing COVID-19: diagnostic importance of detecting E gene of the SARS-CoV-2 genome Iva Barjaktarović, Jelena Stojčević Maletić, Nataša Vučinić, Aleksandra Milutinović, Maja Grujičić, Velibor Čabarkapa
39 [GO] 2023―Jan―09 The prevalence of deep vein thrombosis and associated risk factors among patients with COVID-19 in the North of Iran Maryam Yaseri, Seyyedeh Sahereh Mortazavi Khatibani, Elahe Ghorbani Totkaboni, Haniyeh Sadat Fayazi
40 [GO] 2022―Nov―25 Plain language summary of Pfizer-BioNTech BNT162b2 COVID-19 vaccine safety in participants 16 years or older and protection against COVID-19 in participants 12 years or older Stephen J Thomas, Edson D Moreira, Nicholas Kitchin, Judith Absalon, Alejandra Gurtman, Stephen Lockhart, John L Perez, Gonzalo Pérez Marc, Fernando P Polack, Cristiano Zerbini, Ruth Bailey, Kena A Swanson, Xia Xu, Satrajit Roychoudhury, Kenneth Koury, Salim Bouguermouh, Warren V Kalina, David Cooper, Robert W Frenck, Laura L Hammitt, Özlem Türeci, Haylene Nell, Axel Schaefer, Serhat Ünal, Qi Yang, Paul Liberator, Dina B Tresnan, Susan Mather, Philip R Dormitzer, Uğur Şahin, William C Gruber, Kathrin U Jansen
41 [GO] 2022―Oct―22 Variation analysis of SARS-CoV-2 complete sequences from Iran Jale Moradi, Parnia Moradi, Amir H Alvandi, Ramin Abiri, Mohsen Moghoofei
42 [GO] 2022―Oct―17 Blood types (ABO/Rhesus) and SARS-CoV-2 infection: a retrospective, cross-sectional study in 2828 healthcare workers Betul Copur, Serkan Surme, Ugurcan Sayili, Gulsah Tuncer, Melike Nur Ozcelik, Hulya Yilmaz-Ak, Muge Topal, Sumeyye Ustun-Al, Filiz Pehlivanoglu, Gonul Sengoz
43 [GO] 2022―Sep―26 Reinfection and reactivation of SARS-CoV-2 Razieh Dowran, Amirmasoud Rayati Damavandi, Talat Mokhtari Azad
44 [GO] 2022―Sep―26 Rapid antigen test for SARS-CoV-2: results of validation and use in real life Irena Grmek Kosnik, Urska Dermota, Andrej Golle, Tjasa Zohar Cretnik
45 [GO] 2022―Sep―23 Similarity between cutaneous reactions due to SARS-CoV-2 and its vaccinations Ömer Kutlu, Selami Aykut Temiz
46 [GO] 2022―Sep―16 Relevance of cycle threshold values in mass screening by reverse-transcription-PCR during COVID-19 pandemic in Belgium: a decision-making support? Patrice Dufour, Henry Paridaens, Jean-Marc Senterre, Jean-Marc Minon
47 [GO] 2022―Sep―14 A plain language summary of the Janssen COVID-19 vaccine effectiveness and safety as a single dose and with a booster Frank Struyf, Jerald Sadoff, Karin Hardt, Macaya Douoguih
48 [GO] 2022―Aug―31 Sudden onset of decreased vision following Delta variant of SARS-CoV-2 infection: a case report Akram Sadat Ahmadi, Nazanin Zahra Shafiei-Jandaghi, Kaveh Sadeghi, Mohammadreza Salehi, Talat Mokhtari-Azad, Jila Yavarian
49 [GO] 2022―Aug―08 Digging for the discovery of SARS-CoV-2 nsp12 inhibitors: a pharmacophore-based and molecular dynamics simulation study Fatemeh Sana Askari, Mohsen Ebrahimi, Jabbar Parhiz, Mina Hassanpour, Alireza Mohebbi, Abbas Mirshafiey
50 [GO] 2022―Aug―02 Cholesterol-lowering drugs for high-risk hypercholesterolemia patients with COVID-19 while on Paxlovid™ therapy Alpo Vuorio, Petri T Kovanen, Frederick Raal
51 [GO] 2022―Aug―02 Structural analysis of spike proteins from SARS-CoV-2 variants of concern highlighting their functional alterations Kundan Solanki, Sajjan Rajpoot, Ashutosh Kumar, Kam Y J Zhang, Tomokazu Ohishi, Nik Hirani, Khandu Wadhonkar, Pramod Patidar, Qiuwei Pan, Mirza S Baig
52 [GO] 2022―Jul―22 Tripartite communication in COVID-19 infection: SARS-CoV-2 pathogenesis, gut microbiota and ACE2 Sara Ahmadi Badi, Shohreh Khatami, Seyed Davar Siadat
53 [GO] 2022―Jul―19 A rare case of septic pulmonary embolism in co-existence with infective endocarditis and COVID-19 Yusuf Emre Ozdemir, Adile Sevde Demir, Meryem Sahin Ozdemir, Busra Mavi, Can Ozen, Hayat Kumbasar Karaosmanoglu
54 [GO] 2022―Jul―19 Nothing in SARS-CoV-2 makes sense except in the light of RNA modification? Mingmei Zhao, Chunxiao Li, Yu Dong, Xuekun Wang, Wenqing Jiang, Yaogang Chen
55 [GO] 2022―Jul―01 Molecular and antigen tests, and sample types for diagnosis of COVID-19: a review Yujia Zhang, Rachael Garner, Sana Salehi, Marianna La Rocca, Dominique Duncan
56 [GO] 2022―Jul―01 SARS-CoV-2 and its repercussive effect on reproductive health: recent trends Sukanth Kumar Enmozhi, Jerrine Joseph
57 [GO] 2022―Jun―28 IGA nephropathy and spinal epidural abscess after COVID-19 infection: a case report Burak Göre, Ezgi Coşkun Yenigün, Şimal Köksal Cevher, Emre Çankaya, Numan Aydın, Fatih Dede
58 [GO] 2022―Jun―16 A comprehensive account of SARS-CoV-2 genome structure, incurred mutations, lineages and COVID-19 vaccination program Vijay Rani Rajpal, Shashi Sharma, Deepmala Sehgal, Apekshita Singh, Avinash Kumar, Samantha Vaishnavi, Mugdha Tiwari, Hemal Bhalla, Shailendra Goel, Soom Nath Raina
59 [GO] 2022―Jun―15 Clinical course of idiopathic inflammatory myopathies in COVID-19 pandemic: a single-center experience Hakan Apaydin, Abdulsamet Erden, Serdar C Güven, Berkan Armağan, Özlem Karakaş, Bahar Özdemir, Bünyamin Polat, Mehmet Akif Eksin, Ahmet Omma, Orhan Kucuksahin
60 [GO] 2022―Jun―08 Detection of SARS-CoV-2 N501Y mutation among SARS-CoV-2 variants of concern circulating in Northern Cyprus Gulten Tuncel, Mahmut Cerkez Ergoren, Buket Baddal, Pinar Tulay, Cenk Serhan Ozverel, Emrah Guler, Huseyin Kaya Suer, Murat Sayan, Tamer Sanlidag
61 [GO] 2022―Jun―03 Mapping of SARS-CoV-2 spike protein evolution during first and second waves of COVID-19 infections in India Vijay Rani Rajpal, Shashi Sharma, Avinash Kumar, Samantha Vaishnavi, Apekshita Singh, Deepmala Sehgal, Mughdha Tiwari, Shailendra Goel, Soom Nath Raina
62 [GO] 2022―Jun―03 Efficacy and safety of corticosteroid regimens for the treatment of hospitalized COVID-19 patients: a meta-analysis Fangwen Zhou, Jiawen Deng, Kiyan Heybati, Qi Kang Zuo, Saif Ali, Wenteng Hou, Chi Yi Wong, Harikrishnaa Ba Ramaraju, Oswin Chang, Thanansayan Dhivagaran, Zachary Silver
63 [GO] 2022―May―09 Evaluation of SARS-CoV-2 genome detection by real-time PCR assay using pooled specimens Forough Tavakoli, Jila Yavarian, Nazanin Zahra Shafiei Jandaghi, Kaveh Sadeghi, Nastaran Ghavami, Vahid Salimi, Talat Mokhtari-Azad
64 [GO] 2022―Apr―26 Neutralization heterogeneity of circulating SARS-CoV-2 variants to sera elicited by a vaccinee or convalescent Meng Zhang, Yixin Gong, Shunchang Jiao
65 [GO] 2022―Apr―19 Need for more robust research on the effectiveness of masks in preventing COVID-19 transmission Jingjing Nie, Linna Kang, Yaya Pian, Jihong Hu
66 [GO] 2022―Apr―19 Toll-like receptor 4 in COVID-19: friend or foe? Suprabhat Mukherjee
67 [GO] 2022―Apr―11 Evaluation of rapid antigen detection kits for detection of SARS-CoV-2 B.1.617.2 virus Gannon CK Mak, Stephen SY Lau, Kitty KY Wong, Nancy LS Chow, Chi-Shan Lau, Edman TK Lam, Ken HL Ng, Rickjason CW Chan
68 [GO] 2022―Apr―05 Reviewing findings on the polypeptide sequence of the SARS-CoV-2 S-protein to discuss the origins of the virus Alberto Maria Cattaneo
69 [GO] 2022―Apr―04 In silico discovery of non-psychoactive scaffolds in Cannabis halting SARS-CoV-2 host entry and replication machinery Amira R Khattab, Mohamed Teleb
70 [GO] 2022―Mar―21 Can anti-parasitic drugs help control COVID-19? Yasin Panahi, Masoomeh Dadkhah, Sahand Talei, Zahra Gharari, Vahid Asghariazar, Arash Abdolmaleki, Somayeh Matin, Soheila Molaei
71 [GO] 2022―Mar―17 A community call to action: mitigating COVID pandemic’s impact on mental health Wahid Ullah, Muhammad Ilyas, Mukhtar Alam, Jong Bhak, Peter J Tonellato
72 [GO] 2022―Mar―08 Massive third wave of COVID-19 outbreak in Bangladesh: a co-epidemic of dengue might worsen the situation Popy Devnath, Md. Jamal Hossain, Talha Bin Emran, Saikat Mitra
73 [GO] 2022―Mar―01 Airborne transmission of SARS-CoV-2 disease (COVID-19) Mohammad K Parvez, Shama Parveen
74 [GO] 2022―Feb―21 A nomogram predicting the severity of COVID-19 based on initial clinical and radiologic characteristics Hanfei Zhang, Feiyang Zhong, Binchen Wang, Meiyan Liao
75 [GO] 2022―Feb―11 Cervical and preauricular lymphadenopathies as atypical manifestations in the setting of COVID-19: a case report Alireza Ala, Solomon Habtemariam, Samad Shams Vahdati, Aysa Rezabakhsh
76 [GO] 2022―Feb―10 Research progresses in vertical transmission of SARS-CoV-2 among infants born to mothers with COVID-19 Zhoujie Peng, Jing Zhang, Yuan Shi, Ming Yi
77 [GO] 2022―Feb―10 Antineutrophil cytoplasmic antibody positivity and clinical implications in COVID-19 Serdar Can Güven, Hakan Apaydın, Bahar Özdemir, Berkan Armağan, İhsan Ateş, Abdulsamet Erden, Orhan Küçükşahin, Ahmet Omma
78 [GO] 2022―Feb―10 Computed tomography evaluation of pancreatic steatosis: correlation with COVID-19 prognosis Serkan Guneyli, Hakan Dogan, Omer Tarik Esengur, Hur Hassoy
79 [GO] 2022―Jan―31 Efficacy of lopinavir-ritonavir combination therapy for the treatment of hospitalized COVID-19 patients: a meta-analysis Jiawen Deng, Fangwen Zhou, Wenteng Hou, Kiyan Heybati, Saif Ali, Oswin Chang, Zachary Silver, Thanansayan Dhivagaran, Harikrishnaa Ba Ramaraju, Chi Yi Wong, Qi Kang Zuo, Elizabeth Lapshina, Madeline Mellett
80 [GO] 2022―Jan―12 Rethinking methods used to evaluate effectiveness of therapeutics for COVID-19 and other viral respiratory illnesses Jean-François Rossignol
81 [GO] 2022―Jan―12 Anterior ischemic optic neuropathy as a rare manifestation of COVID-19: a case report Khodayar Golabchi, Alireza Rezaee, Davood Aghadoost, Maryam Hashemipour
82 [GO] 2021―Dec―15 A systematic review and meta-analysis of the sensitivity of antibody tests for the laboratory confirmation of COVID-19 Nigel A Makoah, Thomas Tipih, Matefo M Litabe, Mareza Brink, Joseph B Sempa, Dominique Goedhals, Felicity J Burt
83 [GO] 2021―Dec―15 Identifying asymptomatic cases during the mass COVID-19 vaccination campaign: insights and implications for policy makers Francesco Chirico, Gabriella Nucera, Olayinka Ilesanmi, Aanuoluwapo Afolabi, Michal Pruc, Lukasz Szarpak
84 [GO] 2021―Dec―15 Performance of six SARS-CoV-2 RNA detection systems in symptomatic and asymptomatic pediatric and maternal patients Cameron A Brown, Megan H Amerson-Brown, Aliza Rahman, Charity R Webb, Ila R Singh, James J Dunn
85 [GO] 2021―Dec―06 Myocarditis and COVID-19 mRNA vaccines: a mechanistic hypothesis involving dsRNA Gerard Milano, Jocelyn Gal, Anne Creisson, Emmanuel Chamorey
86 [GO] 2021―Dec―03 Efficacy of chloroquine and hydroxychloroquine for the treatment of hospitalized COVID-19 patients: a meta-analysis Jiawen Deng, Fangwen Zhou, Kiyan Heybati, Saif Ali, Qi Kang Zuo, Wenteng Hou, Thanansayan Dhivagaran, Harikrishnaa Ba Ramaraju, Oswin Chang, Chi Yi Wong, Zachary Silver
87 [GO] 2021―Nov―26 A brief review on DNA vaccines in the era of COVID-19 Maryam Shafaati, Massoud Saidijam, Meysam Soleimani, Fereshte Hazrati, Rasoul Mirzaei, Bagher Amirheidari, Hamid Tanzadehpanah, Sajad Karampoor, Sima Kazemi, Bahram Yavari, Hanie Mahaki, Mohsen Safaei, Fatemeh Rahbarizadeh, Pouria Samadi, Yaghoub Ahmadyousefi
88 [GO] 2021―Nov―26 Non-SARS, non-MERS human coronavirus infections and risk of Kawasaki disease: a meta-analysis Pratap Kumar Patra, Rashmi Ranjan Das, Aaqib Zaffar Banday, Mini Singh, Kapil Goyal, Ankur Kumar Jindal, Surjit Singh
89 [GO] 2021―Nov―26 Pediatric multisystem inflammatory syndrome temporally associated with SARS-CoV-2 symptoms in Iran Mehran Akbari, Mojtaba Didehdar, Mohsen Nazari, Davood Azadi
90 [GO] 2021―Nov―12 Detection and predictors of anti-SARS-CoV-2 antibody levels in COVID-19 patients at 8 months after symptom onset Jing Guo, Li Li, Qian Wu, Hongwei Li, Yajie Li, Xinwei Hou, Fangfei Yang, Zhonghua Qin
91 [GO] 2021―Nov―12 Temporal variations of country-specific mutational profile of SARS-CoV-2: effect on vaccine efficacy Sayantan Laha, Raghunath Chatterjee
92 [GO] 2021―Nov―04 The Mu strain: the last but not least circulating ‘variant of interest’ potentially affecting the COVID-19 pandemic Farid Rahimi, Negin Kamali, Amin Talebi Bezmin Abadi
93 [GO] 2021―Nov―04 In-hospital clinical complications of COVID-19: a brief overview Kevin John John, Jemimah Nayar, Ajay Kumar Mishra, Vijairam Selvaraj, Mohammad Saud Khan, Amos Lal
94 [GO] 2021―Nov―04 The third booster vaccination dose against COVID-19: indication for circulating SARS-CoV-2 variants Farid Rahimi, Amin Talebi Bezmin Abadi
95 [GO] 2021―Nov―04 SARS-CoV-2 nomenclature: viruses, variants and vaccines need a standardized naming system Tariq Khan, Syed Muhammad Jamal
96 [GO] 2021―Oct―29 The international treaty for pandemic preparedness and response: same story, different times? Dominique Vervoort, Xiya Ma, Alia Sunderji, Hloni Bookholane
97 [GO] 2021―Oct―19 Rare cutaneous manifestation of COVID-19 infection and Pfizer-BioNTech COVID-19 vaccine with a unique pattern similarity Anthony Fata, Georges Jabbour, Hampig Kourie, Marianne Zoghbi, Elia Kassouf, Antoine Zoghbi
98 [GO] 2021―Oct―14 Detection of SARS-CoV-2 in the sewerage system in Tunisia: a promising tool to confront COVID-19 pandemic Habib Jmii, Hakima Gharbi-Khelifi, Raouia Assaoudi, Mahjoub Aouni
99 [GO] 2021―Oct―08 Computed tomography-positive, SARS-CoV-2 RNA-negative symptomatic contacts of COVID-19 patients: what are their nature and implications? Lei Huang
100 [GO] 2021―Oct―08 A case series of pediatric COVID-19 with complicated symptoms in Iran Fatemeh Cheraghali, Leila Barati, Dayan Amanian, Lobat Shahkar, Maryam Najafinejad, Hamed Naziri, Somayeh Shahabi, Alijan Tabarraei, Alireza Tahamtan
101 [GO] 2021―Sep―22 Association between blood groups and COVID-19 outcome in Iranian patients Ali Asghar Ayatollahi, Bahman Aghcheli, Abolfazl Amini, Hasan Nikbakht, Parastoo Ghassemzadehpirsala, Emad Behboudi, Abdolhalim Rajabi, Alireza Tahamtan
102 [GO] 2021―Sep―21 High-value laboratory testing for hospitalized COVID-19 patients: a review Daniela Cihakova, Michael B Streiff, Steven P Menez, Teresa K Chen, Nisha A Gilotra, Erin D Michos, Kieren A Marr, Andrew H Karaba, Matthew L Robinson, Paul W Blair, Maria V Dioverti, Wendy S Post, Andrea L Cox, Annukka A R Antar
103 [GO] 2021―Sep―10 Fast evolution of SARS-CoV-2 driven by deamination systems in hosts Yanping Zhang, Wen Jiang, Yan Li, Xiaojie Jin, Xiaoping Yang, Pirun Zhang, Wenqing Jiang, Bin Yin
104 [GO] 2021―Sep―02 Serum biochemical parameters as a surrogate marker for chest computed tomography in children with COVID-19 Karuna M Das, Rajvir Singh, Sandeep Subramanya, Shreesh Kumar Ojha, Taleb Almansoori, Dilip Gokhale, Jamal Aldeen Alkoteesh
105 [GO] 2021―Sep―02 mRNA-based COVID-19 vaccines appear not to increase immune events in cancer patients receiving immune checkpoint inhibitors Emre Yekedüz, Rüveyda Ayasun, Elif Berna Köksoy, Güngör Utkan, Yüksel Ürün, Hakan Akbulut
106 [GO] 2021―Aug―09 Harnessing immunological targets for COVID-19 immunotherapy Abhishesh Kumar Mehata, Matte Kasi Viswanadh, Vishnu Priya, Madaswamy S Muthu
107 [GO] 2021―Jul―29 Independent and incremental prognostic value of D-dimer in hospitalized COVID-19 patients Gerald Chi, Sahar Memar Montazerin, Jane J Lee
108 [GO] 2021―Jul―20 Potential drugs against COVID-19 revealed by gene expression profile, molecular docking and molecular dynamic simulation Claudia Cava, Gloria Bertoli, Isabella Castiglioni
109 [GO] 2021―Jul―20 An overview of sex hormones in relation to SARS-CoV-2 infection Marzieh Saei Ghare Naz, Mojdeh Banaei, Sareh Dashti, Fahimeh Ramezani Tehrani
110 [GO] 2021―Jul―20 In silico discovery of SARS-CoV-2 main protease inhibitors from the carboline and quinoline database Eldar Muhtar, Mengyang Wang, Haimei Zhu
111 [GO] 2021―Jul―13 Reappraisal of trifluperidol against Nsp3 as a potential therapeutic for novel COVID-19: a molecular docking and dynamics study Ajita Pandey, Mohit Sharma
112 [GO] 2021―Jul―13 Targeting SARS-CoV-2 nonstructural protein 15 endoribonuclease: an in silico perspective Shafi Mahmud, Abdo A Elfiky, Al Amin, Sumon Chandro Mohanto, Ekhtiar Rahman, Uzzal Kumar Acharjee, Abu Saleh
113 [GO] 2021―Jul―08 Association of anemia and COVID-19 in hospitalized patients Chong Chen, Wenhui Zhou, Wenliang Fan, Xianying Ning, Shuai Yang, Ziqiao Lei, Chuansheng Zheng
114 [GO] 2021―Jul―06 Association of administration of IFN-α with mortality among patients hospitalized with coronavirus disease 2019 Hanqing Liu, Zhouru Ruan, Ziwei Yin, Dan Wu, Hong Zhu
115 [GO] 2021―Jun―30 Safety, efficacy and acceptability of SARS-CoV-2 vaccines in patients with cancer Roy Chebel, Chris Labaki, Maria Farhat, Joseph Kattan
116 [GO] 2021―Jun―22 The COVID-19 pandemic: an increased risk of rheumatoid arthritis Archana Tripathy, Nitish Swain, Bhawna Gupta
117 [GO] 2021―Jun―22 V483A: an emerging mutation hotspot of SARS-CoV-2 Omar Ashwaq, Pratibha Manickavasagam, SK Manirul Haque
118 [GO] 2021―Jun―22 Vertical transmission potential of SARS-CoV-2 from infected mother to twin neonates Liangyu Peng, Suliman Khan, Ashaq Ali, Saeed Ahmed, Liaqat Ali, Guang Han, Yang Jing
119 [GO] 2021―Jun―01 Druggability of cavity pockets within SARS-CoV-2 spike glycoprotein and pharmacophore-based drug discovery Alireza Mohebbi, Fatemeh Sana Askari, Ali Salehnia Sammak, Mohsen Ebrahimi, Zahra Najafimemar
120 [GO] 2021―May―24 Tocilizumab in the treatment of coronavirus disease 2019 pneumonia: real-world data from a case series Ran Cui, Ying Zhu, Yulan Wang, Xiao-Hua Chen, Qiang Li, Sheng-Ming Dai, Qiang Tong
121 [GO] 2021―May―19 Natural selection on synonymous mutations in SARS-CoV-2 and the impact on estimating divergence time Yuanyuan Yu, Yan Li, Yu Dong, Xuekun Wang, Chunxiao Li, Wenqing Jiang
122 [GO] 2021―May―19 SARS-CoV-2 likely targets cellular PDZ proteins: a common tactic of pathogenic viruses Andrew P Rice, Jason T Kimata
123 [GO] 2021―May―12 Predictive values of biochemical markers as early indicators for severe COVID-19 cases in admission Emin Gemcioglu, Mehmet Davutoglu, Ramis Catalbas, Berkan Karabuga, Enes Kaptan, Adalet Aypak, Ayse K Kalem, Mustafa Özdemir, Necati Y Yeşilova, Emra A Kalkan, Musa Civak, Orhan Kücüksahin, Abdulsamet Erden, Ihsan Ates
124 [GO] 2021―Apr―26 An analysis of inhibition of the severe acute respiratory syndrome coronavirus 2 RNA-dependent RNA polymerase by zinc ion: an in silico approach Sina Zoghi, Hossein Jafari Khamirani, Seyed Alireza Dastgheib, Mehdi Dianatpour, Alireza Ghaffarieh
125 [GO] 2021―Apr―22 HIV and COVID-19 pandemic collision: turning challenges into opportunity Stefano Rusconi, Laura Pezzati, Tiziana Formenti, Andrea Giacomelli
126 [GO] 2021―Apr―21 Investigation of the relationship between inherited thrombophilia and novel coronavirus pneumonia Aslihan Kiraz, Seda Guzeldag, Esma Eren, Musa Goksu, Arslan Bayram
127 [GO] 2021―Apr―14 The initial infectious dose of SARS-CoV-2 and the severity of the disease: possible impact on the incubation period Hamid Tayebi Khosroshahi, Alireza Mardomi
128 [GO] 2021―Apr―07 Abnormal myocardial enzymes are important indicators of poor prognosis in COVID-19 patients Jingping Cheng, Wanxin Liu, Siyang Chen, Xiafen Hu, Xiaochen Xiang, Zhongliang Cheng, Shaoqian Cai, Kaiwen Guo, Qiang Wang, Xiaoliu Liu, Qingming Wu
129 [GO] 2021―Apr―06 Xerostomia (dry mouth) in patients with COVID-19: a case series Yaser Fathi, Elaheh Ghasemzadeh Hoseini, Fatemeh Atoof, Reza Mottaghi
130 [GO] 2021―Mar―25 Exploring the binding efficacy of ivermectin against the key proteins of SARS-CoV-2 pathogenesis: an in silico approach Abhigyan Choudhury, Nabarun C Das, Ritwik Patra, Manojit Bhattacharya, Pratik Ghosh, Bidhan C Patra, Suprabhat Mukherjee
131 [GO] 2021―Mar―24 The role of miRNAs in COVID-19 disease Mona Fani, Milad Zandi, Saeedeh Ebrahimi, Saber Soltani, Samaneh Abbasi
132 [GO] 2021―Mar―09 Erythema multiform-like lesions in a patient infected with SARS-CoV-2: a case report Yaser Fathi, Elaheh Ghasemzadeh Hoseini, Reza Mottaghi
133 [GO] 2021―Mar―08 Comparative sequence analysis of SARS-CoV-2 suggests its high transmissibility and pathogenicity Kartika Padhan, Mohammad K Parvez, Mohammed S Al-Dosari
134 [GO] 2021―Mar―02 Computational guided approach for drug repurposing against SARS-CoV-2 Jigisha Anand, Tanmay Ghildiyal, Aakanksha Madhwal, Rishabh Bhatt, Devvret Verma, Nishant Rai
135 [GO] 2021―Feb―24 Epidemiologic features and clinical course of COVID-19: a retrospective analysis of 19 patients in Germany Sara Elgamasy, Eman Elsayed Sakr, Mohamed Gomaa Kamel, Sherief Ghozy, Ghadeer Gamal Elsayed, Mostafa Mahmoud Fahmy, Ahmed Ghazy, Mohamed Maged Nagaty Ibrahim, Mostafa Ebraheem Morra
136 [GO] 2021―Feb―22 Scouting the receptor-binding domain of SARS coronavirus 2: a comprehensive immunoinformatics inquisition Zaira Rehman, Ammad Fahim, Muhammad Faraz Bhatti
137 [GO] 2021―Feb―09 The long-quarantined case of COVID-19 with prolonged viral shedding and intermittent fever for more than 70 days Eijiro Yamada, Emi Ishida, Yasuyo Nakajima, Kazuhiko Horiguchi, Shunichi Matsumoto, Shuichi Okada, Wataru Kamitani, Masanobu Yamada
138 [GO] 2021―Feb―04 What is the intermediate host species of SARS-CoV-2? Thomas Friend, Justin Stebbing
139 [GO] 2021―Feb―03 SARS-CoV-2 direct real-time polymerase chain reaction testing in laboratories with shortage challenges Taghreed Alaifan, Asmaa Altamimi, Dalia Obeid, Turki Alshehri, Shaihana Almatrrouk, Ahmed Albarrag
140 [GO] 2021―Jan―28 Asymptomatic carriers of coronavirus disease 2019 among healthcare workers in Isfahan, Iran Hamed Fakhim, Elahe Nasri, Shima Aboutalebian, Sahar Gholipour, Mahnaz Nikaeen, Afsane Vaezi, Somayeh Mousavi, Sama Faramarzi, Armin Farhang, Shaghayegh Haghjooy Javanmard, Mehrdad Salahi, Ali Darakhshandeh, Kazem Ahmadikia, Hossein Mirhendi
141 [GO] 2021―Jan―26 Severe acute respiratory syndrome coronavirus 2 viral load in respiratory and feces specimens of children with coronavirus disease 2019 Xiang Ma, Liang Su, Lu Cheng, Zhaohua Zhang, Jing Sun, Miao Liu, Jing Wang, Xuemei Jiang, Yun Zhang, Yuling Han, Zhongfa Zhang, Zhongtao Gai
142 [GO] 2021―Jan―25 Clinical characteristics of outpatients and inpatients with COVID-19 in Bushehr: a report from the south of Iran Mohsen Keshavarz, Ahmad Tavakoli, Sareh Zanganeh, Mohammad Javad Mousavi, Katayoun Vahdat, Mehdi Mahmudpour, Iraj Nabipour, Amirhossein Darabi, Saeid Keshmiri
143 [GO] 2021―Jan―13 Mechanisms of infection by SARS-CoV-2, inflammation and potential links with the microbiome María Magdalena Aguirre García, Javier Mancilla-Galindo, Mercedes Paredes-Paredes, Álvaro Zamudio Tiburcio, Nydia Ávila-Vanzzini
144 [GO] 2021―Jan―07 A new perspective of the chemistry and kinetics of inactivation of COVID -19 coronavirus aerosols Michael L Hitchman
145 [GO] 2020―Dec―24 Relationship between IL-6 and COVID-19: to be considered during treatment Hafize Seda Vatansever, Eda Becer
146 [GO] 2020―Dec―16 Pandemic response management framework based on efficiency of COVID-19 control and treatment Mustapha D Ibrahim, Fatima AS Binofai, Reem MM Alshamsi
147 [GO] 2020―Dec―15 Can natural detergent properties of bile acids be used beneficially in tackling coronavirus disease-19? Yashwant Kumar, Reena Yadav, Alka Bhatia
148 [GO] 2020―Nov―30 Phylogenomics and phylodynamics of SARS-CoV-2 genomes retrieved from India Sameera Farah, Ashwin Atkulwar, Manas Ranjan Praharaj, Raja Khan, Ravikumar Gandham, Mumtaz Baig
149 [GO] 2020―Nov―26 The role of artificial intelligence in tackling COVID-19 Neelima Arora, Amit K Banerjee, Mangamoori L Narasu
150 [GO] 2020―Nov―26 Phylogenetic and whole genome analysis of first seven SARS-CoV-2 isolates in Bangladesh Nadim Sharif, Shuvra K Dey
151 [GO] 2020―Nov―04 LIF and the lung’s stem cell niche: is failure to use LIF to protect against COVID-19 a grave omission in managing the pandemic? Su M Metcalfe
152 [GO] 2020―Oct―28 A multiple-center clinical evaluation of a new real-time reverse transcriptase PCR diagnostic kit for SARS-CoV-2 Jing-Jing Guo, Yan-Hua Yu, Xue-Ying Ma, Ya-Nan Liu, Qian Fang, Pei Qu, Jie Guo, Jin-Li Lou, Ya-Jie Wang
153 [GO] 2020―Oct―27 Perversely expressed long noncoding RNAs can alter host response and viral proliferation in SARS-CoV-2 infection Rafeed Rahman Turjya, Md. Abdullah-Al-Kamran Khan, Abul Bashar Mir Md. Khademul Islam
154 [GO] 2020―Oct―22 Clinical characteristics and outcomes of discharged COVID-19 patients with reoccurrence of SARS-CoV-2 RNA Jing Wu, Xiao-ying Xia, He-lei Liu, Hong Xia, Wen-xiang Huang, Bei Jia, Feng-ying Peng
155 [GO] 2020―Oct―14 A comprehensive review about SARS-CoV-2 SK Manirul Haque, Omar Ashwaq, Abdulla Sarief, Abdul Kalam Azad John Mohamed
156 [GO] 2020―Oct―13 Implications of current and future approaches to coronavirus disease 2019 testing Rasheid Smith, Sean M Geary, Aliasger K Salem
157 [GO] 2020―Oct―08 The potential of lactoferrin, ovotransferrin and lysozyme as antiviral and immune-modulating agents in COVID-19 Jaclyn Kelly Mann, Thumbi Ndung'u
158 [GO] 2020―Oct―08 In silico analysis of protein/peptide-based inhalers against SARS-CoV-2 Saad Salman, Fahad Hassan Shah, Maham Chaudhry, Muniba Tariq, Muhammad Yasir Akbar, Muhammad Adnan
159 [GO] 2020―Aug―26 Investigation of compatibility of severe acute respiratory syndrome coronavirus 2 reverse transcriptase-PCR kits containing different gene targets during coronavirus disease 2019 pandemic Figen Sarıgül, Osman Doluca, Sıla Akhan, Murat Sayan
160 [GO] 2020―Aug―26 Genetic and pathogenic characterization of SARS-CoV-2: a review Afsane Bahrami, Gordon A Ferns
161 [GO] 2020―Aug―18 A flow virometry process proposed for detection of SARS-CoV-2 and large-scale screening of COVID-19 cases Niraja Soni, Puja Pai, Gurumurthy Raja Krishna Kumar, Venkatesh Prasad, Santanu Dasgupta, Bhaskar Bhadra
162 [GO] 2020―Aug―17 Susceptibility of the Iranian population to severe acute respiratory syndrome coronavirus 2 infection based on variants of angiotensin I converting enzyme 2 Alireza Mohebbi, Fatemeh Sana Askari, Mohsen Ebrahimi, Mana Zakeri, Mohammad Yasaghi, Hanieh Bagheri, Naeme Javid
163 [GO] 2020―Aug―12 Thoughts on detecting tissue distribution of potential COVID-19 receptors Hongtao Tang, Xiaosheng Lu, Shuyan Qie, Jianing Xi
164 [GO] 2020―Jul―29 In silico identification of conserved cis-acting RNA elements in the SARS-CoV-2 genome Bader Y Alhatlani
165 [GO] 2020―Jul―27 COVID-19: studying the global pandemic - foreword Stefano Rusconi, Frederick G Hayden
166 [GO] 2020―Jul―27 Therapeutic and vaccine strategies against SARS-CoV-2: past, present and future Mubasher Rehman, Isfahan Tauseef, Bibi Aalia, Sajid Hussain Shah, Muhammad Junaid, Kashif Syed Haleem
167 [GO] 2020―Jun―26 COVID-19 in homeless populations: unique challenges and opportunities Brian Conway, David Truong, Kelli Wuerth
168 [GO] 2020―Jun―12 COVID-19 and coronaviral hepatitis: evidence of collateral damage Mohammad K Parvez
169 [GO] 2020―Jun―12 Transmission and clinical characteristics of asymptomatic patients with SARS-CoV-2 infection Jie Tan, Shousheng Liu, Likun Zhuang, Lizhen Chen, Mengzhen Dong, Jie Zhang, Yongning Xin
170 [GO] 2020―May―29 A suspected case of COVID-19 turned into a confirmed case: a case report from Iran Di Yang, Kai Wei, Xuesong Gao, Yijin Zhang, Ping Gao, Hongjie Li, Xiaomin Liu, Zheng Yuan, Te Xiao, Wenshan Zhao, Xuefei Duan
171 [GO] 2020―May―26 Severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) infection: let the virus be its own demise John Nemunaitis, Laura Stanbery, Neil Senzer
172 [GO] 2020―May―20 Comparison of the COVID-2019 (SARS-CoV-2) pathogenesis with SARS-CoV and MERS-CoV infections Mona Fani, Ali Teimoori, Shokouh Ghafari
173 [GO] 2020―May―12 Prediction and analysis of key protein structures of 2019-nCoV Qihao Li, Wen Peng, Yu Ou
174 [GO] 2020―Apr―24 The divergence between SARS-CoV-2 and RaTG13 might be overestimated due to the extensive RNA modification Yue Li, Xinai Yang, Na Wang, Haiyan Wang, Bin Yin, Xiaoping Yang, Wenqing Jiang
175 [GO] 2020―Apr―17 Pros and cons of the application of evolutionary theories to the evolution of SARS-CoV-2 Yue Li, Xinai Yang, Na Wang, Haiyan Wang, Bin Yin, Xiaoping Yang, Wenqing Jiang
 [1] 

175 Results       Page 1



[de][en]

Last change 2023―Oct―27 12:08:13 UTC

© Daten-Quadrat 2022       Done in 0.004 sec